Sotorasib as Fourth-Line Treatment in Pancreatic Cancer: A Case Report and Literature Review.

Abstract excerpt

The molecular pathogenesis of exocrine pancreatic cancer involves mutations K-RAS, TP53, CDKN2A, and SMAD4. The KRAS oncogene leads to constitutively active tumor cell proliferation and is present in 90% of unresectable or metastatic pancreatic adenocarcinomas. Of these, the G12C variant of K-RAS genes accounts for 1-2% of mutations. A 65-year-old woman initially diagnosed with T3N0M0 pancreatic adenocarcinoma,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Fluorouracil
• Share to Irinotecan
• Share to Leucovorin